neotiv

neotiv GmbH is a German digital health company focused on developing digital biomarkers and software platforms for the early detection and monitoring of neurodegenerative diseases, particularly Alzheimer's disease. Founded in 2017 as a spin-off from Otto von Guericke University Magdeburg, neotiv collaborates closely with the German Centre for Neurodegenerative Diseases (DZNE) to integrate neuroscientific research into user-friendly mobile applications for smartphones and tablets. The company aims to enable early diagnosis and improve patient care through biologically valid cognitive assessments. These assessments are designed to monitor cognitive health and disease progression, allowing for remote and unsupervised testing. neotiv's digital platform also supports the integration of fluid biomarkers to enhance diagnostic accuracy. Their solutions target healthcare providers, researchers, and patients, empowering them with tools for cognitive health measurement and support. With significant funding secured, neotiv is poised to expand its impact in the fight against Alzheimer's disease.

• Employees 29
• Founded 2017
• Annual Revenue $1900000
• Total Funding $10028900